Drug Resistance in Glioma Cells Induced by a Mesenchymal–Amoeboid Migratory Switch
- Supplementary File 1:
ZIP-Document (ZIP, 1123 KiB)
Ketchen, S.E.; Gamboa-Esteves, F.O.; Lawler, S.E.; Nowicki, M.O.; Rohwedder, A.; Knipp, S.; Prior, S.; Short, S.C.; Ladbury, J.E.; Brüning-Richardson, A. Drug Resistance in Glioma Cells Induced by a Mesenchymal–Amoeboid Migratory Switch. Biomedicines 2022, 10, 9. https://doi.org/10.3390/biomedicines10010009
Ketchen SE, Gamboa-Esteves FO, Lawler SE, Nowicki MO, Rohwedder A, Knipp S, Prior S, Short SC, Ladbury JE, Brüning-Richardson A. Drug Resistance in Glioma Cells Induced by a Mesenchymal–Amoeboid Migratory Switch. Biomedicines. 2022; 10(1):9. https://doi.org/10.3390/biomedicines10010009
Chicago/Turabian StyleKetchen, Sophie E., Filomena O. Gamboa-Esteves, Sean E. Lawler, Michal O. Nowicki, Arndt Rohwedder, Sabine Knipp, Sally Prior, Susan C. Short, John E. Ladbury, and Anke Brüning-Richardson. 2022. "Drug Resistance in Glioma Cells Induced by a Mesenchymal–Amoeboid Migratory Switch" Biomedicines 10, no. 1: 9. https://doi.org/10.3390/biomedicines10010009